Tenax Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2 | $0 |
Gross Profit | 1 | |||
EBITDA | -10,847 | -10,408 | -6,267 | -3,954 |
EBIT | -11,792 | -11,338 | -6,312 | -3,952 |
Net Income | -10,847 | -10,408 | -6,267 | -3,960 |
Net Change In Cash | 0 | 0 | 2 | 0 |
Free Cash Flow | -6,263 | -6,967 | -3,527 | -3,087 |
Cash | 105,462 | 111,447 | 94,851 | 98,310 |
Basic Shares | 39,572 | 36,584 | 15,271 | 21,161 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7 | -113 | -108 | |
EBITDA | -17,579 | -7,679 | -10,930 | -32,364 |
EBIT | -17,625 | -7,686 | -11,043 | -32,473 |
Net Income | -17,602 | -7,710 | -11,047 | -32,474 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,811 | -5,903 | -12,015 | -10,861 |
Cash | 94,851 | 9,792 | 2,123 | 5,583 |
Basic Shares | 15,271 | 248 | 18 | 12 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.27 |
2025-03-31 | -$0.28 |
2024-12-31 | -$0.18 |
2024-09-30 | -$0.19 |
